BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Malaguarnera G, Pennisi M, Bertino G, Motta M, Borzì AM, Vicari E, Bella R, Drago F, Malaguarnera M. Resveratrol in Patients with Minimal Hepatic Encephalopathy. Nutrients 2018;10:E329. [PMID: 29522439 DOI: 10.3390/nu10030329] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Benedicto A, Sanz E, Márquez J. Ocoxin as a complement to first line treatments in cancer. Int J Med Sci 2021;18:835-45. [PMID: 33437220 DOI: 10.7150/ijms.50122] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kim YK, Song J. Therapeutic Applications of Resveratrol in Hepatic Encephalopathy through Its Regulation of the Microbiota, Brain Edema, and Inflammation. J Clin Med 2021;10:3819. [PMID: 34501267 DOI: 10.3390/jcm10173819] [Reference Citation Analysis]
3 Moore A, Beidler J, Hong MY. Resveratrol and Depression in Animal Models: A Systematic Review of the Biological Mechanisms. Molecules 2018;23:E2197. [PMID: 30200269 DOI: 10.3390/molecules23092197] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
4 Pennisi M, Di Bartolo G, Malaguarnera G, Bella R, Lanza G, Malaguarnera M. Vitamin D Serum Levels in Patients with Statin-Induced Musculoskeletal Pain. Dis Markers 2019;2019:3549402. [PMID: 31019583 DOI: 10.1155/2019/3549402] [Reference Citation Analysis]
5 Heidari R. Brain mitochondria as potential therapeutic targets for managing hepatic encephalopathy. Life Sciences 2019;218:65-80. [DOI: 10.1016/j.lfs.2018.12.030] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
6 Kronsten VT, Tranah TH, Pariante C, Shawcross DL. Gut-derived systemic inflammation as a driver of depression in chronic liver disease. J Hepatol 2021:S0168-8278(21)02180-2. [PMID: 34800610 DOI: 10.1016/j.jhep.2021.11.008] [Reference Citation Analysis]
7 Malaguarnera M, Latteri S, Bertino G, Madeddu R, Catania VE, Currò G, Borzì AM, Drago F, Malaguarnera G. D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis. Clin Exp Gastroenterol 2018;11:373-80. [PMID: 30323642 DOI: 10.2147/CEG.S172663] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
8 Taherian M, Norenberg MD, Panickar KS, Shamaladevi N, Ahmad A, Rahman P, Jayakumar AR. Additive Effect of Resveratrol on Astrocyte Swelling Post-exposure to Ammonia, Ischemia and Trauma In Vitro. Neurochem Res 2020;45:1156-67. [PMID: 32166573 DOI: 10.1007/s11064-020-02997-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 Grosso G. Effects of Polyphenol-Rich Foods on Human Health. Nutrients 2018;10:E1089. [PMID: 30110959 DOI: 10.3390/nu10081089] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
10 Pennisi M, Di Bartolo G, Malaguarnera G, Bella R, Lanza G, Malaguarnera M. Vitamin D Serum Levels in Patients with Statin-Induced Musculoskeletal Pain. Dis Markers 2019;2019:3549402. [PMID: 31019583 DOI: 10.1155/2019/3549402] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
11 Eftekar M. The association between hepatic encephalopathy/minimal hepatic encephalopathy and depressive and anxiety disorders: a systematic review. Australas Psychiatry 2020;28:61-5. [DOI: 10.1177/1039856219875054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
12 Stacchiotti A, Favero G, Rezzani R. Resveratrol and SIRT1 Activators for the Treatment of Aging and Age-Related Diseases. In: A. Badria F, editor. Resveratrol - Adding Life to Years, Not Adding Years to Life. IntechOpen; 2019. [DOI: 10.5772/intechopen.78977] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
13 Malaguarnera L. Influence of Resveratrol on the Immune Response. Nutrients 2019;11:E946. [PMID: 31035454 DOI: 10.3390/nu11050946] [Cited by in Crossref: 106] [Cited by in F6Publishing: 98] [Article Influence: 35.3] [Reference Citation Analysis]
14 Zhang Y, Tan SL, Du J, Chen Y, Jia J, Feng JG, Liu KX, Zhou J. Dexmedetomidine alleviates neuroinflammation, restores sleep disorders and neurobehavioral abnormalities in rats with minimal hepatic encephalopathy. Int Immunopharmacol 2021;96:107795. [PMID: 34162157 DOI: 10.1016/j.intimp.2021.107795] [Reference Citation Analysis]
15 Kronsten VT, Shawcross DL. Hepatic encephalopathy and depression in chronic liver disease: is the common link systemic inflammation? Anal Biochem 2021;:114437. [PMID: 34715068 DOI: 10.1016/j.ab.2021.114437] [Reference Citation Analysis]
16 Barone R, Rizzo R, Tabbì G, Malaguarnera M, Frye RE, Bastin J. Nuclear Peroxisome Proliferator-Activated Receptors (PPARs) as Therapeutic Targets of Resveratrol for Autism Spectrum Disorder. Int J Mol Sci 2019;20:E1878. [PMID: 30995737 DOI: 10.3390/ijms20081878] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
17 Malaguarnera M, Llansola M, Balzano T, Gómez-Giménez B, Antúnez-Muñoz C, Martínez-Alarcón N, Mahdinia R, Felipo V. Bicuculline Reduces Neuroinflammation in Hippocampus and Improves Spatial Learning and Anxiety in Hyperammonemic Rats. Role of Glutamate Receptors. Front Pharmacol 2019;10:132. [PMID: 30858801 DOI: 10.3389/fphar.2019.00132] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
18 Ridola L, Nardelli S, Gioia S, Riggio O. Quality of life in patients with minimal hepatic encephalopathy. World J Gastroenterol 2018; 24(48): 5446-5453 [PMID: 30622374 DOI: 10.3748/wjg.v24.i48.5446] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
19 Hosseini S, Ebrahimi A, Bagheri F, Emami Y, Esmaeilzadeh E, Azarpira N, Ebrahimi S, Ashkani-esfahani S. Effect of Resveratrol on Thioacetamide-induced Liver Damage in Rat Models. Hepat Mon 2020;20. [DOI: 10.5812/hepatmon.103902] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Malaguarnera M, Khan H, Cauli O. Resveratrol in Autism Spectrum Disorders: Behavioral and Molecular Effects. Antioxidants (Basel) 2020;9:E188. [PMID: 32106489 DOI: 10.3390/antiox9030188] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
21 Rafe T, Shawon PA, Salem L, Chowdhury NI, Kabir F, Bin Zahur SM, Akhter R, Noor HB, Mohib MM, Sagor MAT. Preventive Role of Resveratrol Against Inflammatory Cytokines and Related Diseases. Curr Pharm Des 2019;25:1345-71. [PMID: 30968773 DOI: 10.2174/1381612825666190410153307] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
22 Abozaid OAR, Sallam MW, El-sonbaty S, Aziza S, Emad B, Ahmed ESA. Resveratrol-Selenium Nanoparticles Alleviate Neuroinflammation and Neurotoxicity in a Rat Model of Alzheimer’s Disease by Regulating Sirt1/miRNA-134/GSK3β Expression. Biol Trace Elem Res. [DOI: 10.1007/s12011-021-03073-7] [Reference Citation Analysis]
23 Vargas-Pozada EE, Muriel P. Herbal medicines for the liver: from bench to bedside. Eur J Gastroenterol Hepatol 2020;32:148-58. [PMID: 31895207 DOI: 10.1097/MEG.0000000000001485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Khanna A, Anamika, Chakraborty S, Tripathi SJ, Acharjee A, Bs SR, Trigun SK. SIRT1 activation by resveratrol reverses atrophy of apical dendrites of hippocampal CA1 pyramidal neurons and neurobehavioral impairments in moderate grade hepatic encephalopathy rats. J Chem Neuroanat 2020;106:101797. [PMID: 32334029 DOI: 10.1016/j.jchemneu.2020.101797] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
25 Sharma P, Kumar A, Singh D. Dietary Flavonoids Interaction with CREB-BDNF Pathway: An Unconventional Approach for Comprehensive Management of Epilepsy. Curr Neuropharmacol 2019;17:1158-75. [PMID: 31400269 DOI: 10.2174/1570159X17666190809165549] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]